Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients
- PMID: 1806285
- DOI: 10.1248/cpb.39.2647
Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients
Abstract
A fragment corresponding to N-terminal octaeicosapeptide of rat parathymosin alpha was synthesized by assembling 5 peptide fragments, followed by deprotection with 1 M trifluoromethanesulfonic acid-thioanisole (molar ratio 1:1) in trifluoroacetic acid in the presence of dimethylselenium. Incubation of impaired T-lymphocytes isolated from uremic patients with the synthetic parathymosin alpha fragment 1-28 showed no immunological restoring effect, but when it was administered together with thymosin alpha 1, it appeared to suppress the restoring effect of the thymosin alpha 1 on the impaired T-lymphocytes of uremic patients.
Similar articles
-
Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.Biotechnol Ther. 1993;4(3-4):221-37. Biotechnol Ther. 1993. PMID: 8292971
-
Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients.Chem Pharm Bull (Tokyo). 1989 Sep;37(9):2467-71. doi: 10.1248/cpb.37.2467. Chem Pharm Bull (Tokyo). 1989. PMID: 2605693
-
Synthesis of deacetylthymosin beta 11 and its effect on the impaired T-lymphocytes of a uremic patient with common variable immunodeficiency.Biotechnol Appl Biochem. 1988 Dec;10(6):576-88. Biotechnol Appl Biochem. 1988. PMID: 3266074
-
Is thymosin alpha 1 a thymic hormone?Clin Immunol Immunopathol. 1992 Dec;65(3):195-200. doi: 10.1016/0090-1229(92)90146-f. Clin Immunol Immunopathol. 1992. PMID: 1451325 Review. No abstract available.
-
Thymalfasin: an immune system enhancer for the treatment of liver disease.J Gastroenterol Hepatol. 2004 Dec;19 Suppl 6:S69-72. doi: 10.1111/j.1440-1746.2004.03635.x. J Gastroenterol Hepatol. 2004. PMID: 15546253 Review.
Cited by
-
A standardized randomized 6-month aerobic exercise-training down-regulated pro-inflammatory genes, but up-regulated anti-inflammatory, neuron survival and axon growth-related genes.Exp Gerontol. 2015 Sep;69:159-69. doi: 10.1016/j.exger.2015.05.005. Epub 2015 May 15. Exp Gerontol. 2015. PMID: 25981742 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources